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ABSTRACT
INTRODUCTION
Scientific name - Barleria prionitis
Common name - Porcupine flower
HABITAT
RATIONALE AND NOVELTY OF THE STUDY
Ethnomedical information about B. prionitis
Family Acanthaceae consists of a large number of medicinal plants and 
is well known for its use in ethnomedicine. The prionitis species of the 
genus Barleria provides a variety of traditions properties. The whole 
plant or its specific parts (leaf, stem, root, bark, and flower) have been 
utilized for the treatment of catarrhal affections [6], ulcer, whooping 
cough, inflammations, glandular swellings, urinary infection, jaundice, 
fever, stomach disorders, and as diuretic and tonic. It is likewise used 
in urinary infection, jaundice, hepatic obstruction, and dropsy, and the 
paste of the roots is applied to benefit to boils and glandular swellings. 
It is also utilized for the treatment of anemia, toothache, and bacterial 
disorders. The flora is, especially, well recognized for caring for bleeding 
gums and toothache. Due to its antiodontalgic property, it is as well-
known as “Vajradanti” [7]. Some tribal communities utilize the leaves for 
the treatment of piles and to control irritation. The plant is also utilized 
for the stiffness of limbs, enlargement of the scrotum, and sciatica [8-11].
Pharmacological activities of B. prionitis
Owing to its traditional use, B. prionitis has been studied for different 
types of pharmacological activities. Numerous in vitro and in vivo 
studies on different cell lines and animals have been reported. The 
present review is focused on giving an overview of the pharmacological 
activities that have been reported on B. prionitis in the past and present.
Antibacterial activity
Different solvent extracts from leaves and stem parts of B. prionitis L. 
exhibited antibacterial activity against all Gram-positive bacteria 
studied (Bacillus pumilus, Bacillus subtilis, Streptococcus pyogenes, 
and Bacillus cereus) and Gram-negative bacteria (Escherichia coli, 
Serratia marcescens, Comamonas acidovorans, and Pseudomonas 
aeruginosa) [12]. Maximum inhibition was delivered by methanol 
leaf extract against B. cereus which was followed by pet ether leaf 
extract against E. coli. Minimum inhibition was shown by pet ether leaf 
extract against Alcaligenes faecalis, followed by methanol bark extract 
against A. faecalis. Antibacterial activity of the various extracts of 
B. prionitis was compared to the standard antibacterial agent ampicillin, 
tetracycline, and streptomycin, and it appeared to be almost the 
same [13]. In another study, the petroleum ether extract of B. prionitis 
was most dynamic against Pseudomonas putida and B. subtilis. While 
the ethanol extract of B. Prionitis was against P. putida [14]. Some 
antibacterial phytochemicals include balarenone, pipataline, and 
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Barleria prionitis is a famous perennial plant commonly known as porcupine flower or Vajradanti. It is a shrub with yellow flowers and
 two  flat seeds shielded with matted hairs,  inhabit most parts of India.  Various parts of the plant such as leaves, roots,  aerial parts, 
flowers, and stems are used in the traditional system of medicine. Conventionally, various infusions are prepared using the plant parts 
and  utilized  for the treatment of  different kinds of  diseases.  Owing to its  incredible odontalgic  property,  it  is  extensively used in 
treating  bleeding  gums and  toothache.  From the pharmacological  point,  the  plant  has  been effectively  screened for  antibacterial, 
antifungal, antiviral, anti-inflammatory,  antifertility,  antioxidant,  enzyme inhibitory,  hepatoprotective,  antihypertensive,  anticancer,  and 
anticataract  activities.  Compounds such as tannins,  saponins,  glycosides,  phenolic  acids,  phytosterols,  and  terpenes  have  been 
identified in the plant.  The plant contains some specific  compounds such as  barlenoside,  barlerine,  acetylbarlerine,  and balarenone 
and  some  common  secondary  metabolites  such  as  lupeol,  β-sitosterol,  vanillic  acid,  and  syringic  acid.  This  review  provides  morphological, 
ethnomedical, pharmacological, and phytochemical data of the plant  B. prionitis.
B.  prionitis  is  commonly  found  in  shrub  jungles  and  wayside 
thickets  from  plains  to  500  m.  Common.  Tropical  Africa,  Tropical  Asia, 
Sri  Lanka,  Pakistan,  India,  Malaysia.  It  is  commonly  found  in  the 
following  states  of  India-Andaman  and  Nicobar  Islands,  Andhra 
Pradesh,  Assam,  Bihar,  Chhattisgarh,  Delhi,  Goa,  Gujarat,  Jharkhand, 
Karnataka, Kerala, Madhya Pradesh, Maharashtra, Orissa, Rajasthan,
 Tamil Nadu, Uttarakhand, Uttar Pradesh, and West Bengal [5].
Barleria  prionitis  also  known  as  the  porcupine  flower,  which
 belongs  to  the  family  Acanthaceae  and  genus  Barleria.  It  
is  native  to  India,  also  distributed  widely  throughout  Asia 
including Malaysia,  Pakistan, Philippines,  Sri  Lanka,  Bangladesh, 
Yemen and  tropical  Africa  [1,2]  Sri  Lanka  and  Eastern  
Southern  and Central  Africa.  It  is  an  erect,  perennial,  
prickly,  and  evergreen  shrub,  usually  single-stemmed, 
growing  to  about  1.5  m  in  height  from  a  single  taproot.  Lateral 
roots  branching  in  all  directions.  The leaves are up to 100 
mm  long  and  40  mm  wide,  oval-shaped  though  narrow  at  both 
ends (ellipsoid).  The base of  the leaves  is  protected  by  three  to
 five  sharp,  10-20  mm  long,  pale-colored  spines.  The  
yellow-orange  tubular  flowers  with several  long  protruding  
stamens.  Flowers  are  packed  in bunches  tightly  together
 at  the  top  of  the  plant,  but  they  also  occur  singly  at  the  
base  of  leaves.  Seed  capsule  which  is 
oval-shaped has two fairly  large,  flat  seeds,  shielded with matted
 hairs  with  a  sharp  pointed  beak.  Stems  and  branches  are  
stiff  and  smooth  and  light  brown  to  light  gray  in  color 
[3,4].  The taxonomical classification of B. prionitis is given in
 Tables 1 and 2.
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13,14-secco-stigmasta-5, 14-diene-3-a-ol have been isolated from the 
ethanolic extract of B. prionitis, and these compounds showed a strong 
antibacterial activity against B. cereus and P. aeruginosa [15].
Antifungal activity
The methanolic extract of B. prionitis was considered to have a check on 
Candidiasis and other oral infections, as its bark showed potent activity 
against the oral fungi such as Saccharomyces cerevisiae, Candida albicans 
strain 1, and C. albicans strain 2, when compared to the standard drug 
amphotericin-B [16]. In another investigation, the leaf exudates and leaf 
tissue sap of B. prionitis L. have been assessed for antifungal activities 
against some fungi such as Curvularia lunata, Curvularia clavata, 
Alternaria alternata, Nigrospora oryzae, and Cladosporium oxysporum. 
The percentage inhibition of spore germination was calculated, and 
result revealed 40-85% inhibition of all of the species [17].
Antiviral activity
Iridoid glycosides and three phenylpropanoid glycosides, namely, 
luteoside A, luteoside B, and luteoside C were isolated from B. prionitis 
and shown to have potent in vitro activity against respiratory syncytial 
virus [18].
Anthelmintic activity
Aqueous and ethanolic extract of the whole plant of B. prionitis 
exhibited anthelmintic activity using Pheretima posthuma worms in 
a dose-dependent manner giving the shortest time of paralysis (P) 
at 50, 75 mg/ml and death (D) with 100 mg/ml concentration when 
compared to standard anthelmintic drug albendazole [19,20].
Antifertility activity
The methanolic root extract of B. prionitis L. was given orally to 
male rats (100 mg/d). The duration of the study was 60 days, and 
the extract reduced the fertility of male rats by 100%. Antifertility 
effects of Barleria appeared to be arbitrated by conflicts in Leydig and 
Sertoli cells functions, resulting in the physiomorphological events 
of spermatogenesis. [21] Antispermatogenic activity is also shown 
by this [22-24]. In another study done by us, an active component 
β-sitosterol (BS) was isolated from the methanolic root extract of B. 
Prionitis, and its antifertility potential was evaluated in the male albino 
rats. The rats were orally administered olive oil (Group-I, control), BS at 
the dose level of 5 (Group II), 15 (Group III), and 25 mg/kg body weight 
(BW) (Group IV) for 60 days. BW was measured weekly. The results 
exhibited that BS from the roots of B. prionitis impairs spermatogenesis 
and fertility that recommends that BS from B. prionitis can be used for 
the development of the male contraceptive drug, which has very limited 
available options [25].
Antioxidant activity
The antioxidant capacity and the reducing power were found highest 
in the methanolic leaf and stem extract as inhibitory concentration 
(IC50) values were 63.41±0.32 and 81.69±0.40, respectively. These 
results may be due to the presence of phenolic contents such as 
barlerinoside, shanzhiside methyl ester, barlerin, acetylbarlerin, 
7-methoxydiderroside, and lupulinoside [26]. In another study, 
antioxidant activity of various fractions of 90% methanolic extract 
was determined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
assay. The IC50 value of hexane, chloroform, ethyl acetate, and butanol 
Antidiabetic activity
Alcoholic extract of leaf and root of B. prionitis was tested for their 
antidiabetic activity in normal and alloxan-induced diabetic rats, 
before and 2 weeks after administration of drugs. Effects demonstrated 
a significant reduction in blood glucose level and glycosylated 
hemoglobin. A significant increase was observed in serum insulin 
level and liver glycogen level, whereas the decrease in the BW was 
arrested by administration of a leaf extract to the animals. This work 
suggested that alcoholic leaf extract of B. prionitis could be considered 
as one of the comparatively harmless and with fewer side effects herbal 
drug for the treatment of diabetes mellitus [30]. In another study, the 
potency of alcoholic and aqueous extracts of leaf, stem, and root was 
compared with that of chlorpropamide at a dose of 200 and 100 mg/kg, 
respectively. The blood glucose level was measured calorimetrically. 
Alcoholic and aqueous extracts of leaf and root caused a significant fall 
in blood glucose level in diabetic rats. From this study, it was concluded 
that B. prionitis is almost as effective as chlorpropamide in reducing the 
sugar levels [31].
Glutathione S-transferase, acetylcholinesterase inhibitory activity
A new compound, balarenone, along with three known compounds, 
pipataline, lupeol, and 13,14-seco-stigmasta-5,14-diene-3-α-ol was 
isolated from the ethanolic extract of B. prionitis of Sri Lankan origin. 
All four of these expressed moderate inhibitory activity against the 
enzymes glutathione S-transferase and acetylcholinesterase [15].
Anticataract activity
Anticataract activity of B. prionitis was estimated using selenite- and 
galactose-induced cataract models in a study. The rats in the test 
gathering were infused with B. prionitis 4 hrs before the selenite 
administration. B. prionitis was administered to the test rats at the 
dose levels of 200 and 400 mg/kg orally, and control rats received only 
vehicle every day. Cataract stages were assessed at normal intervals. 
Morphological valuation verified that selenite-treated rats exhibits 










B. prionitis: Barleria prionitis
Table 2: Vernacular names
Sanskrit Vajradanti, Kurantaka, Koranta
Marathi Kalsunda, kholeta, pivalakoranta
Tamil Araniyaccokicceti, manjachemulli, mirutam, mituri, 
muli, mulli, mulliver, pitakantakacceti
Kannada Gorante, gorantedai, mullu jaali, mullu madarangi, 
mullugoranta
Malayalam Manjakkanakambaram, Kanakambaram
Hindi Kanakambar, Vajradanti, kat-sareya, katsareya, peela 
bansa
English Porcupine flower, Crossandra, Barleria
soluble  fractions  of  methanolic  extract  was  calculated  to 
determine the DPPH radical scavenging property of these fractions, 
and  ascorbic  acid  was  taken  as  standard.  The  maximum  effect 
was demonstrated by the ethyl acetate soluble fractions among 
all. These methanolic extract fractions follow following order - 
ethyl acetate > butanol > chloroform > methanolic > hexane for 
their  antioxidant  activity  [27].  Antioxidant  activity  of  the  ethanol 
extract and aqueous extract of the whole plant of B. prionitis was 
investigated  in  another  study,  and  in  this  DPPH  radical, 
2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic  acid)  scavenging 
activity, hydroxyl radical scavenging activity, reducing power assay, and 
nitrous oxide scavenging activity of various extracts of B. prionitis  were 
calculated to evaluate the radical scavenging potential.  Ethanol extract 
was  the  more  effective  antioxidant  as  compared  to  the  aqueous 
extract.  A  direct  relationship  can  be  concluded  between  the 
antioxidant activity and the phenolic content of B. prionitis [28], which 
was determined using Folin–Ciocalteu reagent.  Antioxidant activity was 
observed in some glycosides which have been isolated from the aerial
 parts  of  B.  prionitis,  namely,  barlerinoside,  shanzhiside  methyl 
ester,  6-O-trans-p-coumararoyl-8-O-acetylshanzhiside  methyl  ester, 
barlerin, acetylbarlerin, 7-methoxydiderroside, and lupinoside [29].
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increased opacities as compared with normal. A fall in the glutathione 
level and an increase in the malondialdehyde levels were seen in control 
rather than normal lenses. These results revealed that the onset and 
progression of cataract were hindered in selenite and so as in galactose-
induced cataract. Slit-lamp microscopic images proved its anticatract 
activity, which can be due to its antioxidant potential [32].
Anticancer activity
The oil prepared with the whole plant is applied externally during 
the acute stage of cysts in the blood vessels [33]. It shows its effective 
anticancer properties.
Anti-inflammatory activity
In a study, various extracts from the B. prionitis roots were extracted. 
These extracts were evaluated for their anti-inflammatory activity 
using carrageenan-induced rat paw edema at the dose levels of 200 
and 400 mg/kg orally. The aqueous extract was found most active, it 
was then fractionated into four major fractions, and these fractions 
were also screened by the same tests. AQSE fractions (FR-IV) of 
B. prionitis showed maximum percentage inhibition of rat paw edema 
(52.56% and 55.76%) at a dose of 200 and 400 mg/kg, respectively. 
Anti-inflammatory activity was found to be dose dependent for all 
four fractions. These results provide a scenario for the use of this plant 
as an anti-inflammatory agent [34]. In another study, TAF fraction 
from the methanol-water extract of B. prionitis Linn. was evaluated 
for anti-inflammatory activity against different acute and chronic 
animal test models. Carrageenan, histamine, and dextran which are 
known inflammagens had anti-inflammatory effect produced by 
it. Adrenalectomized rats show normal anti-inflammatory activity 
that expresses that the effect of fraction “TAF” is not controlled by 
the pituitary-adrenal axis. “TAF” also showed inhibition of vascular 
permeability and leukocytes migration in vivo into the site of 
inflammatory insult. Ibuprofen was used as a standard reference 
drug [35]. In one study, methanolic extract of B. prionitis Linn. at the 
dose of 500 mg/kg showed anti-inflammatory activity in the early stage 
as well as in the late stage (up to 180 minutes) comparable to control 
and standard indomethacin [36].
Antinociceptive activity
One study was undertaken to evaluate the antinociceptive activity 
of 50% ethanolic extract of the flower of B. prionitis in experimental 
animals. The analgesic effect of the extract tested in mice of either 
sex, using an Ugo Basile Analgesy meter. A significant increase was 
measured in the analgesio-meter-induced force (p<0.01-<0.001) at the 
dose level of 50, 100, and 200 mg/kg B. prionitis extract and exhibited 
resistance against pain after 30 minutes equivalent to 26.3-48.23% 
protection [37].
Antihypertensive activity
In a study, antihypertensive activity was evaluated in male albino 
Wistar rats, which were uninephrectomized. Hypertension was induced 
by injecting deoxycorticosterone acetate salt, rats were divided into 
five groups, different dose levels were administered twice a week for 
the duration of 6 weeks, and instead of water, 1% NaCl was provided 
for drinking to the rats. Dose levels of 200 mg/BW and 400 mg/BW 
showed the maximum antihypertensive effect among all. Significant 
antihypertensive activity is developed by the alkaloids, flavonoids, 
steroids, saponins, tannin, and phenolic compounds, whose presence 
in B. prionitis was confirmed through phytochemical screenings [38].
Cytotoxic activity
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay 
on human gingival fibroblast and human dermal fibroblast cell lines 
for ethanolic extract of B. prionitis gave cytotoxicity effects data. The 
concentration of test needed to inhibit cell growth by 50% (CTC50) value 
was found to be more than 1,000 µg/ml. Chlorhexidine was found to be 
more cytotoxic with the CTC50 value of 12.5-25 µg/ml. Ethanolic extract 
of B. prionitis was found significantly cytotoxic (p<0.05) in comparison 
with control [39]. In another study, the methanolic extract of the whole 
plant of B. prionitis was studied for the anticancer activity of the Human 
Ovarian Cancer Cell Line Ovcar-3 and human renal cancer cell line 
786-O in different concentrations (10, 20, 40, and 80 µg/ml) along with 
standard drug adriamycin (doxorubicin) (positive control compound). 
On the basis of the results, we can conclude that these extracts were 
non-cytotoxic [40].
Hepatoprotective activity
Iridoid-enriched fraction (IF) from the ethanol-water extract of the 
aerial parts (leaves and stems) of B. prionitis Linn. was evaluated for 
hepatoprotective activity in various acute and chronic animal test 
models of hepatotoxicity. It afforded significant hepatoprotection 
against carbon tetrachloride, galactosamine, and paracetamol-induced 
hepatotoxicity. Silymarin was used as reference hepatoprotective drug. 
In the safety evaluation study, the oral lethal dose (LD50) was found to be 
more than 3000 mg/kg, with no signs of abnormalities or any mortality 
observed for a 15-day period under observation after a single dose 
of drug administered, whereas intraperitoneal LD50 was found to be 
Central nervous system (CNS) activity
CNS activity of the 70% ethanol extract of leaves of B. prionitis Linn 
(Acanthaceae) in Swiss albino mice was estimated. General behavior 
was studied using actophotometer. According to the study, it was 
observed that the test drug has the stimulant activity. However, in 
comparison with the standard drug, namely, fluoxetine hydrochloride 
available in the market, the stimulant activity seemed to be less. 
Fluoxetine stimulates activity in the animals was found to be 91.93%, 
whereas the test drug from B. prionitis stimulated the animal only 
by 49.72%. The results suggested that ethanol extract of B. prionitis 
exhibits antidepressant activity in testing animal models [42].
Anti-arthritic activity
The anti-arthritic potential of ethyl acetate fractions of chloroform 
extract from leaves of B. prionitis was evaluated by successive 
extraction with chloroform and methanol by the hot Soxhlet extraction 
method. The chloroform extract was further fractionated with solvent 
ethyl acetate to obtain EABP. Acute non-immunological and chronic 
immunological arthritis were induced in rats through formaldehyde 
and Freund’s complete adjuvant, respectively. Then, this fraction was 
evaluated at two doses 125 and 250 mg/kg, fed to the abovementioned 
group of rats. Significant inhibition of edema was observed in both 
acute as well as chronic models in dose-dependent manner. Dose 
level of 250 mg/kg showed most potent and significant paw edema 
inhibition. This finding thus supports the traditional use of B. prionitis 
for rheumatoid arthritis [43].
Mast cell stabilization and membrane protection activity
Hydroalcoholic whole-plant extract of B. prionitis was tested for the 
membrane stabilization and mast cell protection activity, the results 
revealed significant inhibition of the hyposaline-induced erythrocyte 
membrane hemolysis. Mesenteric mast cells degranulation and 
2530±87 mg/kg. SE (n=10) in mice. The studies discovered noteworthy 
and concentration-dependent hepatoprotective potential of 
“IF” because the maximum altered hepatic parameters which 
resulted in liver damage of the experimental rodents was reversed by  
it [41].
Larvicidal activity
Larvicidal  activity  of  various  extracts  of  B.  prionitis  was  estimated  against 
the Japanese Encephalitis vector, Culex tritaeniorynchus in Tamil Nadu, 
India. To identify the active principle present in the promising fraction 
obtained in Chloroform: Methanol extract. The B. prionitis leaf extracts 
were  tested,  employing  the  World  Health  Organization 
procedure against fourth instar larvae of C. tritaeniorhynchus, 
and  the  larval  mortalities  were  recorded  at  various 
concentrations  (6.25  µg/ml);  the  24  hrs  lethal  concentration 
values  of  the  B.  prionitis  leaf  extracts  were  determined  following 
Probit  analysis.  This  investigation proved that  B.  prionitis  could be 
possibly  utilized  as  an  important  component  in  the  Vector  control 
program for the eradication of different harmful diseases [44].
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hemolysis of the erythrocytes was significantly reduced in the extract-
treated rats [45].
The data on the pharmacological action of B. prionitis are listed in 
Table 3.
PHYTOCONSTITUENTS IN B. PRIONITIS
Secondary metabolites play an essential role for the economic 
importance of medicinal plants, although it’s not only economical 
also a core prospective for the betterment of our health. Preliminary 
Table 3: Pharmacological action of Barleria prionitis 
Parts of plant Type of extract/active principle Animal model/microorganism/cell lines/
tissues/assay
Uses References
Leaf Different solvent extract
Petroleum ether extract, ethanol 
extract
Balarenone, pipataline, and 
13,14-secco-stigmasta-5, 
14-diene-3-a-ol isolated from ethanol 
extract
Gram-positive bacteria (Bacillus pumilus, 
B. subtilis, Streptococcus pyogenes, and 
Bacillus cereus) and Gram-negative 
bacteria (Escherichia coli, Serratia 
marcescens, Comamonas acidovorans, and 
Pseudomonas aeruginosa)
Pseudomonas putida and Bacillus subtilis





Leaf exudates and 
leaf tissue sap
Methanolic extract Saccharomyces cerevisiae, Candida albicans 
strain 1, and Candida albicans strain 2
Curvularia lunata, Curvularia clavata, 




Flavonol glycoside - the 
iridoid glycosides and three 
phenylpropanoid glycosides, 
named luteoside A, luteoside B and 
luteoside C
Respiratory syncytial virus Antiviral activity [18]













Various fractions of 90%
Methanolic extract






















Rats Anticataract activity [32]
Whole plant Oil Cysts in acute stages of blood vessels Anticancer activity [33]
Roots Various extracts











Flower 50% ethanolic extract Mice Antinociceptive 
activity
[37]







Human gingival fibroblast and human 
dermal fibroblast cell lines
Human ovarian cancer cell line Ovcar-3 and 
human renal cancer cell line 786-O
Cytotoxic activity [39]
[40]
Aerial parts  
(leaves and stems)





Leaves 70% ethanol extract Swiss albino mice Central nervous 
system activity
[42]




Leaves Chloroform: Methanol, Acetone: 
Chloroform fractions of methanol 
extract
Culex tritaeniorynchus Larvicidal activity [44]
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phytochemical screening showed presence of phytochemicals 
such as alkaloid (by Mayer’s reagent test, Hager’s reagent test, 
Wagner’s reagent test, and Dragendorff ’s reagent test), flavonoids 
(by alkaline reagent test and Shinoda test), saponins (Frothing 
test), terpenoids (dinitrophenylhydrazine test), phytosterol 
(Liebermann’s test and Liebermann–Burchard test), phenolic 
compound and tannin (FeCl3, lead acetate test, and bromine water 
test), essential oil, proteins, and amino acids (Millon’s test, Biuret 
test, and ninhydrin test), carbohydrates (Molisch test, Fehling’s 
solution A, Fehling’s solution B, and Benedict’s test), glycosides 
(Borntrager’s test and legal’s test) [15,28]. Its aerial parts contain 
glycosides such as barlerinoside, shanzhiside methyl ester, 
lupulinoside, 7-methoxydiderroside [45] barlerin, acetylbarlerin, 
and verbascoside [18]; terpenoid such as lupeol, pipataline, and 
balarenone; and flavones such as apigenin 7-O-β-D-glucoside [16] 
and luteolin-7-o-glucoside [45]. Leaves were reported to contain 
phenolic acids such as Melilotic acid [46], syringic acid, vanillic acid, 
and p-hydroxybenzoic acid and flavones such as 6-hydroxyflavone 
and scutellarin [47]. Roots contain phytosterol BS [25]. A brief 
summary of phytochemical constituents isolated from B. prionitis 
is given Table 4.
CONCLUSION
According to ethnomedical study, B. prionits is very effective and 
safe for medicinal uses. The qualitative and quantitative analysis 
reported the presence of many bioactive constituents. Currently, some 
of the phytoconstituents have been isolated and identified from B. 
prionits. These compounds and crude extracts have been screened for 
pharmacological activities by in vivo and in vitro models. The structural 
activity relation between isolated compounds and their target sites 
in the human body should be meticulously studied further. Analytical 
characterization of active principle, developing new strategies in 
clinical trials, and product development will facilitate B. prionits to be 
considered as a potent herbal drug for the treatment of various chronic 















C25H38O16 Iridoid diglucoside Antioxidant activity [45]
7-methoxydiderroside Aerial 
parts

















Melilotic acid Leaves C9H10O3 Phenolic acid Antioxidant activity, antiulcer 
activity
[46]







Table 4: Phytochemical constituents identified, isolated from Barleria prionitis 
(Contd...)
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Class Possible activity Reference
Syringic acid Leaves C9H10O5 Phenolic acid Antioxidant activity, anticancer 
activity, antimicrobial activity, 




6-hydroxyflavone Leaves C15H10O3 Flavone Anti-inflammatory activity, 
antioxidant activity, anticancer 
activity
[47]
β-sitosterol Roots C29H50O Phytosterols Anti-inflammatory activity, 
anticancer activity, 
anthelminthic activity, cytotoxic 
activity, antisteroidogenic 
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